Trial Profile
Interleukin antagonists in active cryopyrin-associated periodic syndromes
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Anakinra (Primary) ; Canakinumab (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use